Le Lézard
Classified in: Science and technology
Subjects: Conference, Product/Service, Trade Show

Eclypsium Supply Chain Security Platform Protects GenAI Infrastructure with Addition of Hardware and Training Model Assessment Capabilities


RSA Conference ? Eclypsium, the supply chain security company protecting critical hardware, firmware, and software, today announced new GenAI assessment capabilities for its Supply Chain Security Platform. The new capabilities help secure the fundamental layers of the generative artificial intelligence (GenAI) tech stack through support for NVIDIA hardware and popular GenAI foundation models.

As demand for GenAI skyrockets, IT infrastructure is changing rapidly to accommodate training and inference requirements. For example, data center operators are rethinking how they design their facilities to accommodate GenAI workloads with new types of power and cooling systems, and accelerated adoption of such technologies as optical interconnects.

As the GenAI tech stack becomes more complex, the IT industry must address security concerns. Eclypsium's added support for NVIDIA hardware, such as the NVIDIA H100 Tensor Core GPU, means cloud services providers and other data center operators are able to identify vulnerabilities and insecure configurations and detect compromise, including the presence of implants and backdoors. Meanwhile, the addition of popular GenAI foundation models to Eclypsium's supply chain intelligence allows organizations to better understand and compare the risk of various closed- and open-source GenAI foundation models.

"Today, GenAI impacts every organization as we learn how it can make people more productive and our products more effective," said Eclypsium CEO and co-founder Yuriy Bulygin. "While GenAI is transforming the way we interact with technology and the world, it creates unique security challenges. We need to understand how to securely build, deploy, and use GenAI models and agents, and how to protect the infrastructure they run on. Eclypsium has developed capabilities to ensure integrity and security of HPC servers, GPUs, and other AI compute resources to protect those fundamental layers of the GenAI infrastructure."

The new capabilities from Eclypsium allow users to continuously monitor and remediate risks in popular NVIDIA hardware used to train GenAI models. As with standard server infrastructure, the systems used to run GenAI workloads are composed of hardware and firmware components, each with complex supply chains. Threats at this fundamental level are virtually impossible to detect and remediate without visibility. The Eclypsium platform provides the third-party assurance and validation that cloud services providers and other data center operators need to ensure that their GenAI hardware infrastructure can be trusted.

Support for popular GenAI models allows Eclypsium customers to easily compare the vulnerabilities and software characteristics of models used to train GenAI applications, including Claude (Anthropic), ColBERT (Stanford University), Command R+ (Cohere), GPT (Open AI), DBRX (DataBricks), Gemini (Google), Llama (Meta), Mixtral (Mistral AI), RoBERTa (Meta), WizardLM (Microsoft), and Zephyr (Hugging Face). This enhanced supply chain intelligence enables teams building both internal and commercial GenAI applications to make risk-informed decisions when choosing a foundation model.

To learn more about the new GenAI assessment capabilities, read Eclypsium's blog post or visit Eclypsium at Booth 226 at the 2024 RSA Conference this week in San Francisco.

ABOUT ECLYPSIUM

Eclypsium's cloud-based platform provides digital supply chain security for critical software, firmware and hardware in enterprise infrastructure. Eclypsium helps enterprises and government agencies mitigate risks to their infrastructure from complex technology supply chains. For more information, visit eclypsium.com.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: